Trisalus Life Sciences, Inc. TLSI Stock Forecast
AI-powered price prediction and analysis for Trisalus Life Sciences, Inc. · Total · absolute moveSwitch to Alpha
See TLSI's Exact Price Target · Create a free account and follow this stock to unlock its full AI forecast — 3 stocks free.
Price Chart
Key Statistics
About Trisalus Life Sciences, Inc.
Trisalus Life Sciences, Inc. (TLSI) operates within the Industrial Applications and Services sector, specifically in the Surgical & Medical Instruments & Apparatus industry.
Latest News
Where TLSI sits on the market map
Surgical & Medical Instruments & Apparatus Peers
Companies sharing the same SEC industry code, one row per issuer, largest first - a classification match, not a curated list of competitors.
| Company | AI Signal | Market Cap | P/E |
|---|---|---|---|
| TLSI Trisalus Life Sciences, Inc. | ▲ | $240M | – |
| SYK Stryker Corp | ▼ | $112.48B | 30.4x |
| MMM 3m Co | ▶ | $85.26B | 29.4x |
| BSX Boston Scientific Corp | ▼ | $63.97B | 21.9x |
| BDX Becton Dickinson & Co | ▼ | $52.78B | 62.9x |
| MDLN Medline Inc. | ▶ | $48.08B | – |
| RMD Resmed Inc | ▼ | $34.94B | 23.2x |
| DXCM Dexcom Inc | ▼ | $33.10B | 38.5x |
| WST West Pharmaceutical Services Inc | ▼ | $26.96B | 49.0x |
| SOLV Solventum Corp | ▼ | $14.96B | 9.9x |
| BAX Baxter International Inc | ▶ | $13.32B | – |
| PEN Penumbra Inc | ▼ | $12.65B | 98.8x |
| GMED Globus Medical Inc | ▼ | $10.59B | 22.3x |
| GKOS Glaukos Corp | ▲ | $9.77B | – |
| PODD Insulet Corp | ▼ | $9.62B | 23.8x |
| HAE Haemonetics Corp | ▼ | $5.52B | 58.6x |
| TFX Teleflex Inc | ▼ | $5.43B | – |
| MMSI Merit Medical Systems Inc | ▼ | $5.35B | 40.0x |
| STVN Stevanato Group S.P.A. | ▲ | $5.26B | 8.4x |
| MMED Minimed Group, Inc. | ▶ | $5.06B | – |
| HTFL Heartflow, Inc. | ▲ | $4.43B | – |
| ICUI Icu Medical Inc/De | ▼ | $4.18B | 298.6x |
| IRTC Irhythm Holdings, Inc. | ▼ | $3.60B | – |
| PLSE Pulse Biosciences, Inc. | ▲ | $3.25B | – |
| ATRC Atricure, Inc. | ▶ | $2.94B | 825.4x |
| UFPT Ufp Technologies Inc | ▶ | $2.30B | 32.1x |
| INSP Inspire Medical Systems, Inc. | ▲ | $2.03B | 14.0x |
| LMAT Lemaitre Vascular Inc | ▼ | $1.90B | 31.3x |
| KMTS Kestra Medical Technologies, Ltd. | ▲ | $1.71B | – |
| ATEC Alphatec Holdings, Inc. | ▲ | $1.69B | – |
| NVCR Novocure Ltd | ▲ | $1.68B | – |
| DRTS Alpha Tau Medical Ltd. | ▲ | $1.16B | – |
| TNDM Tandem Diabetes Care Inc | ▲ | $1.15B | – |
| IRMD Iradimed Corp | ▼ | $1.14B | 52.3x |
| AORT Artivion, Inc. | ▼ | $1.07B | – |
| IART Integra Lifesciences Holdings Corp | ▶ | $1.05B | – |
| PRCT Procept Biorobotics Corp | ▲ | $1.04B | – |
| BVS Bioventus Inc. | ▼ | $943M | 20.0x |
| BBNX Beta Bionics, Inc. | ▲ | $913M | – |
| SIBN Si-Bone, Inc. | ▶ | $892M | – |
| SGP Spyglass Pharma, Inc. | ▲ | $827M | – |
| MDXG Mimedx Group, Inc. | ▶ | $682M | 29.3x |
| KIDS Orthopediatrics Corp | ▼ | $589M | – |
| SSII Ss Innovations International, Inc. | ▲ | $541M | – |
| TCMD Tactile Systems Technology Inc | ▼ | $528M | 22.8x |
| DCTH Delcath Systems, Inc. | ▲ | $523M | 211.6x |
| ANGO Angiodynamics Inc | ▲ | $487M | – |
| SGHT Sight Sciences, Inc. | ▲ | $485M | – |
| BWAY Brainsway Ltd. | ▲ | $463M | – |
| CERS Cerus Corp | ▲ | $455M | – |
| NPCE Neuropace Inc | ▶ | $439M | – |
| RCEL Avita Medical, Inc. | ▲ | $415M | – |
| OFIX Orthofix Medical Inc. | ▼ | $391M | – |
| CARL Carlsmed, Inc. | ▲ | $381M | – |
| EMBC Embecta Corp. | ▶ | $365M | 5.4x |
| OBIO Orchestra Biomed Holdings, Inc. | ▲ | $345M | – |
| CLPT Clearpoint Neuro, Inc. | ▲ | $294M | – |
| ANIK Anika Therapeutics, Inc. | ▼ | $277M | – |
| MOBI Mobia Medical, Inc. | ▼ | $277M | – |
| TMCI Treace Medical Concepts, Inc. | ▲ | $268M | – |
FAQ
Is Trisalus Life Sciences, Inc. a good stock to buy?
Our AI analyzes Trisalus Life Sciences, Inc. daily. Check the signal above for the latest recommendation. Always do your own research before investing.
How accurate are Trisalus Life Sciences, Inc. predictions?
For TLSI, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 10.0%, measured on 289 forecast dates between 2023-11-17 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 14.0%, measured on 332 forecast dates between 2023-11-17 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are forecasts updated?
Trisalus Life Sciences, Inc. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 16, 2026.
Ready to invest smarter? · Join thousands of investors using AI-powered stock predictions
Sign Up FreeLooking for a deeper analysis of Trisalus Life Sciences, Inc.? View full institutional-grade analysis on Intratio →
AI predictions are based on historical patterns and should not be the sole basis for investment decisions. Past performance does not guarantee future results. Always do your own research.